Pay in 4 interest-free payments of $5.65 Learn more
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
S.RicqE
In SURPASS-2, tirzepatide was compared directly with semaglutide (another GLP-1 receptor agonist) in patients with type 2 diabetes, with participants continuing background metformin therapy as a requirement for enrollment
If you want to compare notes with semaglutide, our guide on how long semaglutide takes to suppress appetite is a useful companion read
Pre-diabetic patients and those with hypertension may qualify
Evidence suggests that GLP-1 signaling may mediate inflammatory pathways involved in some metabolic, pulmonary and neurologic disorders
US$ 23.42
US$ 22.32
US$ 23.75
US$ 23.99
US$ 22.65
